Fig. 1 · Structure
Documents & Downloads
Efmoroctocog alfa
rFVIIIFc
Efmoroctocog alfa is a recombinant human coagulation factor VIII-Fc fusion protein (rFVIIIFc) designed to enhance hemostatic function in hemophilia A. This reagent exhibits prolonged circulation in the bloodstream, making it vital for studying factor VIII deficiencies and developing therapeutic strategies. Research applications include investigating the molecular dynamics of coagulation pathways and evaluating potential gene therapies for hemophilia A.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1270012-79-7 |
| Applications | rFVIIIFc |
| Molecular Weight | 220 kDa |
| Synonyms | Eloctate |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.